Colleen Maher

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

Adam J. Widman, Minita Shah, Amanda Frydendahl et al. · Nature Medicine · 2024 · 99 citations · Full text

Medicine, Biomedical Engineering, Oncology +16

LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade

Ronglai Shen, Michael A. Postow, Matthew Adamow et al. · Science Translational Medicine · 2021 · 98 citations · Full text

Life Sciences, Immunology, Oncology +15

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

Jeppe Sejerø Holm, Samuel A. Funt, Annie Borch et al. · Nature Communications · 2022 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Updated safety and efficacy of durvalumab (MEDI4736), an anti-PD-L 1 antibody, in patients from a squamous cell carcinoma of the head and neck (SCCHN) expansion cohort

Neil H. Segal, S.‐H.I. Ou, Ani Sarkis Balmanoukian et al. · Annals of Oncology · 2016 · 38 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia

James W. Smithy, Matthew J. Pianko, Colleen Maher et al. · Journal of Immunotherapy · 2020 · 17 citations · Full text

Life Sciences, Immunology, Oncology +17